[Congress] ICI Europe Summit - 27- 29 November 2018 - Berlin - Germany

ICI Europe Summit – 27-29 Novembre – Berlin, Allemagne

This industry focused conference uses the cancer immunity cycle as a framework from which to investigate the most promising immuno-oncology approaches.

Come & plan on meeting with Keith Payne, Business Account Manager to discuss your project and investigate how Oncodesign can support your Immuno-Oncology (IO) pipeline.


[Press Release] Centre Georges François Leclerc Presents the Detailed Results of the First Two Stages of its Clinical Study in Lung Cancer at the EANM Congress


[Congress] Hamamatsu Forum- 19 October 2018 - Hamamatsu – Japan

Hamamatsu Forum – 19 October – Hamamatsu – Japan

Meet Olivier Duchamp – Head in vivo sciences Dpt., Xavier Morge - Chief Business Development & Marketing Officer and Francis Bichat - Technology Director, to discuss how in vivo PDX & PDX-derived models should be incorporated into all stages of drug discovery process, from target to clinical development.

KEYNOTE LECTURE - “Novel holistic and integrative approach of drug discovery and development using PDX models against cancer”
Olivier Duchamp, PhD, Head in vivo sciences Dpt., Oncodesign.

When? Friday, October 19th 2018, 10:30am
Where? Session 1 - PDX mouse: Current status and future for human-cancer model

[Congress] GMP Annual Symposium - 17-19 October 2018 - Paris -France

GMP Annual Symposium – 17-19 October – Paris - France

Oncodesign is pleased to be one of sponsors of the « Groupe de Métabolisme et Pharmacocinétique (GMP) » for their 30th annual meeting: « Birth, growth and new horizons of metabolism and PK sciences”.

Join Yann Courbebaisse - one of the chairmen of the discussion

DISCUSSION - SESSION 6 - ”DMPK in pediatric patients : Current Points to Consider”

When?  Thursday, October 18, 2018, 5pm – 06:15pm

By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.